Statistics

	Views
Early efficacy results in the Alumites study: A randomized, controlled, multicenter, phase IV study with house dust mites subcutaneous immunotherapy. Two months symptoms and medication scores	1

Select a period of time:

	Views
Early efficacy results in the Alumites study: A randomized, controlled, multicenter, phase IV study with house dust mites subcutaneous immunotherapy. Two months symptoms and medication scores	1

	Views
February 2026	1

	Views
South Africa	1

	Views
Sandton	1

RUNA digital repository